Lars-Kristian Bråten, MBA

Fifteen years of experience in private equity (capital market transactions, M&A and deal making) and audit. Former audit manager at Ernst & Young, Switzerland. MBA from NHH Bergen and State Authorized Public Accountant (Norway). Former board observer at BRAHMS AG
(acquired by Thermo Fisher Scientific) PharmaSwiss SA (acquired by Valeant Pharmaceuticals). HBM project leader in connection with the BRAHMS trade-sale process.